Aftercare of Dupuytren's Contracture

Links shared publicly online about this topic.

  • 836
    total visits

Aftercare of Dupuytren's Contracture

dupuytren-patienteninfo.de

Helpful information concerning the aftercare of Dupuytren's Contracture.

View full resource at dupuytren-patienteninfo.de

Tags: Dupuytren Contracture

  • Share

Most Recently Shared on September 30, 2010 at 2:35 pm By:

Health_CK Catherine K

Just added http://bit.ly/bN8a2W to the Aftercare of Dupuytren Contracture WisdomCard http://bit.ly/btG9Ew @organizedwisdom

2 years ago...

Dupuytren's Contracture Treatment, Risk Factors, Causes, Symptoms - MedicineNet

medicinenet.com — “Read about Dupuytren's contracture treatment options: Xiaflex injection, needle aponeurotomy, ultrasound, and cortisone injection. Learn causes, risk factors, and symptoms.View full resource at medicinenet.com

  • View Related
  • Share

Most Recently Shared on March 8, 2012 at 6:49 pm By:

MedicineNet MedicineNet.com Health Site

What are risk factors for a Dupuytren's contracture? http://t.co/c35LB0hf

3 months ago...

What are the causes of Dupuytren's contracture?

healthtap.com — “What are the causes of Dupuytren's contracture?View full resource at healthtap.com

  • View Related
  • Share

Most Recently Shared on February 20, 2012 at 1:48 am By:

Auxilium reports positive data from XIAFLEX retrospective commercial patient chart review

news-medical.net — “Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that positive data from a retrospective commercial patient chart review of XIAFLEX (collagenase clostridium histolyticum) used for the treatment of adult Dupuytren's contracture patients with a palpable cord are available via e-posters at the American Society for Surgery of the Hand meeting in Las Vegas.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on September 8, 2011 at 1:52 pm By:

NewsMedical News-Medical.Net Health News

Auxilium reports positive data from XIAFLEX retrospective commercial patient chart review: Auxilium Pharma... http://t.co/przKrLZ

9 months ago...

Top-line results from Auxilium XIAFLEX palpable cord study in Dupuytren's contracture subjects

news-medical.net — “Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line results from a pilot clinical study to assess safety, tolerability, and multiple-dose pharmacokinetics of XIAFLEX (collagenase clostridium histolyticum) in adult Dupuytren's contracture subjects with multiple palpable cords.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on September 7, 2011 at 1:03 pm By:

NewsMedical News-Medical.Net Health News

Top-line results from Auxilium XIAFLEX palpable cord study in Dupuytren's contracture subjects: Auxilium Pharmac... http://t.co/yPwWthU

9 months ago...

Auxilium, BioSpecifics Technologies to invest in cellulite indication for Xiaflex - Medical Marketing and Media

mmm-online.com — “Auxilium Pharmaceuticals has announced plans to invest in an indication for prescription drug Xiaflex (collagenase clostridium histolyticum), which was approved by FDA in February 2010 for adult Dupuytren's contracture patients with a palpable cord, for the treatment of cellulite.View full resource at mmm-online.com

  • View Related
  • Share

Most Recently Shared on September 2, 2011 at 1:44 am By:

Auxilium, BioSpecifics Technologies to invest in cellulite indication for Xiaflex - Medical Marketing and Media

mmm-online.com — “Auxilium Pharmaceuticals has announced plans to invest in an indication for prescription drug Xiaflex (collagenase clostridium histolyticum), which was approved by FDA in February 2010 for adult Dupuytren's contracture patients with a palpable cord, for the treatment of cellulite.View full resource at mmm-online.com

  • View Related
  • Share

Most Recently Shared on September 1, 2011 at 8:02 pm By:

NickCharles507 Nick Charles Health Marketing

Auxilium, BioSpecifics Technologies to invest in cellulite indication for Xiaflex: Auxilium Pharmaceut... http://t.co/w6SBkR8 from MM&M

9 months ago...

Celiac disease and Dupuytren’s contracture | Gluten Free For Good

glutenfreeforgood.com — “Is there a connection? I was diagnosed with Dupuytren's contracture ten years ago. I have it in both my hands and my feet. I also have Celiac disease andView full resource at glutenfreeforgood.com

  • View Related
  • Share

Most Recently Shared on August 28, 2011 at 1:36 pm By:

GFMelissa Melissa Patient Expert

Celiac disease and Dupuytren's contracture: are they related? Please help me find out. http://t.co/KQUn8vy

9 months ago...

Auxilium reports three year data from XIAFLEX CORDLESS study in Dupuytren's contracture

news-medical.net — “Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced three year recurrence data from the Collagenase Optimal Reduction of Dupuytren's - Long-term Evaluation of Success Study (CORDLESS) for XIAFLEX® (collagenase clostridium histolyticum) in the treatment of adult Dupuytren's contracture patients with a palpable cord.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 30, 2011 at 12:57 pm By:

NewsMedical News-Medical.Net Health News

Auxilium reports three year data from XIAFLEX CORDLESS study in Dupuytren's contracture: Auxilium Pharmaceutical... http://bit.ly/m1Xn0c

11 months ago...

Auxilium Pharmaceuticals Announces Results from Three Year CORDLESS Extension Study in Dupuytren's Contracture - Drugs.com MedNews

drugs.com — “- Nominal Recurrence Rate of 34.8 at Three Years for Joints Previously Treated Successfully with XIAFLEX -93 of joints that were successfully treated with XIAFLView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on June 30, 2011 at 12:17 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Auxilium Pharmaceuticals Announces Results from Three Year CORDLESS Extension Study in Dupuytren's Contrac... http://bit.ly/k0qSW2 #drug

11 months ago...

Data Supports Efficacy Of Xiapex(R) (Collagenase Clostridium Histolyticum) As A Treatment Option For Dupuytren's Contracture

medicalnewstoday.com — “Data presented for the first time at the annual congress of the Federation of European Societies for Surgery of the Hand (FESSH), further supports the role of XIAPEX® (collagenase clostridiumView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 26, 2011 at 4:05 pm By:

mnt_bones MNT Bones/Orthopedic Health News

Data Supports Efficacy Of Xiapex(R) (Collagenase Clostridium Histolyticum) As A Treatment Option For Dupuytren's Contr... http://mnt.to/3Wq6

1 year ago...

Xiapex: New option for Dupuytren's contracture | MIMS online

mims.co.uk — “Xiapex has been launched as treatment for Dupuytren's contracture. Treatment for Dupuytren's contracture without surgery.View full resource at mims.co.uk

  • View Related
  • Share

Most Recently Shared on May 6, 2011 at 10:02 am By:

mimsonline MIMS Online Medical Publisher

First injectable treatment for Dupuytren's contracture available: http://bit.ly/mTxcJ4

1 year ago...

First Dupuytren's contracture jab | News | Nursing Times

nursingtimes.net — “People with Dupuytren--™s contracture will now be able to avoid surgery to correct the condition.View full resource at nursingtimes.net

  • View Related
  • Share

Most Recently Shared on April 11, 2011 at 10:10 am By:

Xiapex(R) (Collagenase Clostridium Histolyticum), First Injectable Treatment Indicated For Dupuytren's Contracture, Launched In UK

medicalnewstoday.com — “Xiapex® (collagenase clostridium histolyticum), the first licensed injectable treatment option for Dupuytren's contracture in adult patients with a palpable cord, is now available in the UK.1View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 5, 2011 at 12:05 pm By:

mnt_dermatology MNT Dermatology News Dermatology and Health News

Xiapex(R) (Collagenase Clostridium Histolyticum), First Injectable Treatment Indicated For Dupuytren's Contracture, La... http://mnt.to/3TbH

1 year ago...

Xiapex(R) (Collagenase Clostridium Histolyticum) Authorised In The European Union (EU) For Dupuytren's Contracture

medicalnewstoday.com — “XIAPEX® (collagenase clostridium histolyticum), a new treatment option for Dupuytren's contracture in adult patients with a palpable cord, has been granted marketing authorisation by the EuropView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 3, 2011 at 11:05 am By:

mnt_bones MNT Bones/Orthopedic Health News

Xiapex(R) (Collagenase Clostridium Histolyticum) Authorised In The European Union (EU) For Dupuytren's Contracture http://mnt.to/3RNP

1 year ago...

New Treatment Unlocks Curled Fingers

newswise.com — “A new, nonsurgical treatment now is available for Dupuytren's contracture, a debilitating condition that curls fingers toward the palm.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on January 25, 2011 at 11:24 pm By:

newswise newswise Health Communicator and Health News

Most Emailed: New Treatment Unlocks Curled Fingers: A new, nonsurgical treatment now is available for Dupuytren'... http://bit.ly/giIALN

1 year ago...

Advertisement